BrightGene Bio-Medical Technology Co

BrightGene Bio-Medical Technology Co Dividend

The Dividend of BrightGene Bio-Medical Technology Co (688166.SS) as of Nov 4, 2026 is 0.10 CNY. In the previous year, Dividend was 0.10 CNY — a change of 0.00% (lower).

Dividend

0.10CNY

YoY

0.00%

Dividend yield

0.33 %

Last updated:

How much dividend does BrightGene Bio-Medical Technology Co 2026 pay?

According to the latest status from November 2026, BrightGene Bio-Medical Technology Co paid a total of 0.10 CNY per share in dividends within the last 12 months. With the current BrightGene Bio-Medical Technology Co price of 29.47 CNY, this corresponds to a dividend yield of 0.33 %. A dividend is paid times per year.

At today's price the dividend yield works out to roughly 0.33%. The payout ratio is around 75% of earnings. The dividend has grown at 3.2% per year over the past 5 years.

Historical BrightGene Bio-Medical Technology Co Dividends

A dividend is paid times per year. Last year, the payout months were and July.

Historical BrightGene Bio-Medical Technology Co Dividends
PaydateDividend
0.02CNY
0.10CNY
0.10CNY
0.11CNY
0.12CNY
0.08CNY
0.08CNY

The BrightGene Bio-Medical Technology Co Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.11 CNY
Jan 1, 2024
0.10 CNY
Jan 1, 2025
0.10 CNY
Jan 1, 2026 (e)
0.02 CNY
Jan 1, 2027 (e)
0.02 CNY
Jan 1, 2028 (e)
0.02 CNY
Jan 1, 2029 (e)
0.02 CNY
Jan 1, 2030 (e)
0.02 CNY
The BrightGene Bio-Medical Technology Co Dividend history
YEARDividendYoY
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY0.00%
est0.02CNY-83.33%
0.10CNY0.00%
0.10CNY-15.79%
0.11CNY-5.00%
0.12CNY+42.86%
0.08CNY+2.44%
0.08CNY—
0.00CNY—
0.00CNY—
0.00CNY—
0.00CNY—

BrightGene Bio-Medical Technology Co dividend history and estimates

In 2025, BrightGene Bio-Medical Technology Co paid a dividend amounting to 0.10 CNY. Dividend means that BrightGene Bio-Medical Technology Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
0.08 CNY
0.00 CNY
Jan 1, 2022
0.12 CNY
0.00 CNY
Jan 1, 2023
0.11 CNY
0.00 CNY
Jan 1, 2024
0.10 CNY
0.00 CNY
Jan 1, 2025
0.10 CNY
0.00 CNY
Jan 1, 2026
0.02 CNY
0.00 CNY
Jan 1, 2027 (e)
0.00 CNY
0.02 CNY
Jan 1, 2028 (e)
0.00 CNY
0.02 CNY

Is the BrightGene Bio-Medical Technology Co Dividend Safe?

BrightGene Bio-Medical Technology Co has been increasing the dividend for 0 years.

Over a five-year period, the distribution rose by 3.20%.

Analysts expect a Dividend Cut of -59.18% for the current fiscal year.

BrightGene Bio-Medical Technology Co dividend payout ratio

In 2025, BrightGene Bio-Medical Technology Co had a payout ratio of 74.51%. The payout ratio indicates the percentage of the company's profits that BrightGene Bio-Medical Technology Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
14.12 %
Jan 1, 2022
21.16 %
Jan 1, 2023
23.79 %
Jan 1, 2024
21.44 %
Jan 1, 2025
74.51 %
Jan 1, 2026 (e)
39.91 %
Jan 1, 2027 (e)
1.54 %
Jan 1, 2028 (e)
38.65 %

Dividend Details

Understanding BrightGene Bio-Medical Technology Co's Dividend Distributions

BrightGene Bio-Medical Technology Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining BrightGene Bio-Medical Technology Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

BrightGene Bio-Medical Technology Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in BrightGene Bio-Medical Technology Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

BrightGene Bio-Medical Technology Co Stock analysis

What does BrightGene Bio-Medical Technology Co do? BrightGene Bio-Medical Technology Co., Ltd. generates revenue by researching, developing, and manufacturing biopharmaceuticals, medicines, and special generic active pharmaceutical ingredients and finished dosage forms. The company's product portfolio centers on antifungal, antiviral, and immunosuppressive APIs, alongside other APIs and preparations. Its generic drug offerings specifically include entecavir, caspofungin, micafungin, posaconazole, everolimus, and fondaparinux sodium. The firm sells these products to customers in both domestic and overseas markets. By leveraging its capabilities in producing essential active pharmaceutical ingredients and finished dosage forms, the company serves the broader pharmaceutical sector through its established manufacturing and research operations. BrightGene Bio-Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BrightGene Bio-Medical Technology Co stock

Over the past 12 months, BrightGene Bio-Medical Technology Co paid a dividend of 0.10 CNY . This corresponds to a dividend yield of about 0.33 %. For the coming 12 months, BrightGene Bio-Medical Technology Co is expected to pay a dividend of 0.02 CNY.

The current dividend yield of BrightGene Bio-Medical Technology Co is 0.33 %.

BrightGene Bio-Medical Technology Co pays a dividend, distributed in the months of June, July.

BrightGene Bio-Medical Technology Co paid dividends every year for the past 6 years.

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 0.05 %.

BrightGene Bio-Medical Technology Co is assigned to the 'Health' sector.

In the year 2025, BrightGene Bio-Medical Technology Co distributed 0.1 CNY as dividends.

The dividends of BrightGene Bio-Medical Technology Co are distributed in CNY.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — BrightGene Bio-Medical Technology Co